Germany· DE-A57-2d2c28a7b20b3757
Cystohipp
A medicinal product containing methenamine hippurate, registered in Germany by Dr. Pfleger Arzneimittel Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Methenamine Hippurate
- Manufacturer
- Dr. Pfleger Arzneimittel Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methenamine hippurate in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMethenamine hippurateZydus Lifesciences Limited
- SwedenHiprex 1 g Oralt pulver i dospåseViatris AB
- FinlandHipeksalOy Leiras Finland Ab
- NorwayHiprexViatris AS
- BelgiumVesaphir 1 gGoodlife Specialty
- IrelandMethenamine hippurate Brown & Burk 1 g tabletsBrown & Burk IR Limited
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Vesaphir
- Denmark · Haiprex, Methenamine Hippurate Eql Pharma
- Finland · Hiprex, Methenamine Hippurate Orion
- France · Altaromin
- United Kingdom (Northern Ireland) · Hiprex, Methenamine Hippurate Brown & Burk Uk
- Ireland · Methenamine Hippurate Brown & Burk
- Iceland · Haiprex
- Luxembourg · Vesaphir
- Malta · Methenamine Hippurate Brown & Burk, Methenamine Hippurate Eql Pharma
- Netherlands · Vesaphir
- Norway · Hiprex, Methenamine Hippurate Eql Pharma
- Sweden · Hiprex, Methenamine Hippurate Brown & Burk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/28a079dc-375c-4861-b921-ccacbca9cf43 GET /v1/drugs/28a079dc-375c-4861-b921-ccacbca9cf43?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Methenamine Hippurate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about methenamine hippurate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.